Bausch Health Companies (NYSE:BHC) Shareholders Are up 7.0% This Past Week, but Still in the Red Over the Last Five Years
Bausch Health Companies (NYSE:BHC) Shareholders Are up 7.0% This Past Week, but Still in the Red Over the Last Five Years
Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for those who held Bausch Health Companies Inc. (NYSE:BHC) for five whole years - as the share price tanked 72%. On the other hand the share price has bounced 7.0% over the last week.
长期投资效果很好,但并不总是适用于每只个股。当我们看到其他投资者遭受损失时,心里总是很不舒服。想想那些在五年前就持有Bausch Health Companies Inc.(纽交所:BHC)的人——他们的股价已经暴跌了72%。另一方面,过去一周股价反弹了7.0%。
While the stock has risen 7.0% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us.
虽然股票在过去一周上涨了7.0%,但长期股东仍然处于亏损状态,我们来看看基本面能告诉我们什么。
Bausch Health Companies wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.
Bausch Health Companies在过去十二个月里并未盈利,因此其股价与每股收益(EPS)之间几乎没有强相关性。可以说,营业收入是我们的下一个最佳选择。一般来说,未盈利的公司预计每年营业收入都会增长,而且增幅相当可观。这是因为如果营业收入增长微乎其微,公司是否能够持续经营就令人难以确信,并且它从未盈利。
Over five years, Bausch Health Companies grew its revenue at 1.6% per year. That's not a very high growth rate considering it doesn't make profits. It's not so sure that share price crash of 11% per year is completely deserved, but the market is doubtless disappointed. We'd be pretty cautious about this one, although the sell-off may be too severe. A company like this generally needs to produce profits before it can find favour with new investors.
在五年内,Bausch Health Companies的营业收入年均增长1.6%。考虑到它没有盈利,这个增长率并不高。股价每年下跌11%是否完全合理还有待确认,但市场显然感到失望。我们对此持谨慎态度,尽管抛售可能过于严重。像这样的公司通常需要在找到新投资者之前产生利润。
You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).
您可以在下面的图像中查看收益和营业收入随时间的变化(点击图表查看确切值)。
Take a more thorough look at Bausch Health Companies' financial health with this free report on its balance sheet.
通过这份关于Bausch Health公司的资产负债表的免费报告,深入了解该公司的财务状况。
A Different Perspective
不同的视角
Bausch Health Companies shareholders gained a total return of 3.6% during the year. But that was short of the market average. On the bright side, that's still a gain, and it is certainly better than the yearly loss of about 11% endured over half a decade. So this might be a sign the business has turned its fortunes around. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 1 warning sign for Bausch Health Companies that you should be aware of.
Bausch Health公司的股东在过去一年获得了3.6%的总回报。但这低于市场平均水平。值得高兴的是,这仍然是一个增益,当然比过去五年约11%的年度损失要好。因此,这可能是公司扭转了运势的迹象。虽然考虑市场状况对股价的不同影响非常重要,但还有其他因素更加重要。例如,我们识别出Bausch Health公司有1个警告信号需要引起注意。
Of course Bausch Health Companies may not be the best stock to buy. So you may wish to see this free collection of growth stocks.
当然,Bausch Health公司可能不是最值得买入的股票。因此,您可能希望查看这份免费的增长股票集合。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
请注意,本文中引用的市场回报反映了当前在美国交易所上市股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?对内容有疑虑?请直接与我们联系。或者,发送电子邮件至 editorial-team (at) simplywallst.com。
这篇来自Simply Wall St的文章是一般性的。我们根据历史数据和分析师预测提供评论,采用无偏见的方法,我们的文章并不旨在提供财务建议。它不构成对任何股票的买入或卖出建议,也未考虑到您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均没有持仓。